Volume 8, Issue 1 (6-2021)                   vacres 2021, 8(1): 88-91 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
kiani A, Abedini A, Rouhani Z S, Banitorfi M, Saeidi A, Zaheri H. Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration. vacres 2021; 8 (1) :88-91
URL: http://vacres.pasteur.ac.ir/article-1-276-en.html
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration
Arda Kiani , Atefeh Abedini , Zahra Sadat Rouhani , Mohammadhossein Banitorfi , Amirhossein Saeidi , Hamidreza Zaheri *
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (1793 Views)
Recently the term vaccine-induced immune thrombotic thrombocytopenia (VITT) used for individual which have thrombotic phenomena followed by ChAdOx1 nCoV-19 vaccine (AstraZeneca) administration against SARS coronavirus. Here we report the 27 years old healthy male and known case of G6PD deficiency which come to emergency department with progressive right calf swallow from 12 days ago and hemoptysis from a day ago. he mentioned he had administrated First dose of AstraZeneca vaccine for 3 weeks ago. He admitted with suspected pulmonary thromboembolism (PTE) followed by Deep vein thrombosis (DVT). In color Doppler study there are dilation in right calf vain with elevated lab measurement d-dimer indicated DVT also in computed tomography angiography (CTA) there are some evidence of filling defect in left pulmonary branch and right inferior lobar artery which represent to PTE.
Keywords: Pulmonary Thromboembolism, Deep Vein Thrombosis, ChAd0x1 nCoV-19 Vaccine
Full-Text [PDF 557 kb]   (702 Downloads)    
Type of Study: case report | Subject: Vaccine development, efficacy and safety evaluation
Received: 2022/01/4
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.